Physician profile
Warwick Aiken
NPI 1972599751
$2,514.21
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,409 · 2020: $106.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $397.55 | 2019 | |
| Novo Nordisk INC | $263.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $240.08 | 2019 | |
| Pfizer INC. | $236.82 | 2019-2020 | |
| Astellas Pharma US INC | $231.23 | 2019 | |
| Merck Sharp & Dohme LLC | $197.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $150.27 | 2019 | |
| Amgen INC. | $131.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $127.95 | 2019-2020 | |
| Amarin Pharma, INC. | $121.20 | 2019 | |
| Abbvie INC. | $112.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.56 | 2019 | |
| Lilly USA, LLC | $53.70 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.03 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.92 | 2019 | |
| Vifor Pharma, INC. | $16.65 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.25 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.34 | 2019 | |
| Shire North American Group INC | $12.63 | 2019 | |
| Genentech USA, INC. | $11.50 | 2019 | |
| Eisai INC. | $10.80 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warwick Aiken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.